OMB Control #: 0925-0668
Dear Dr. X,
The NIAID Office of Research Training and Special Programs (ORTSP) is conducting a short survey to obtain information regarding key aspects of the NIAID National Research Service Award (NRSA) Institutional Research Training Grant (T32) programs.
The NIAID research training programs have been a foundation for the development of the next generation of academic researchers. As you are aware, in the past two years, the NIH Director, Dr. Francis Collins, had commissioned two working groups of the NIH Advisory Committee to the Director (ACD) which provided reports and recommendations in regards to research training of future scientists (Biomedical Workforce Working Group Report, Physician-Scientist Workforce Working Group Report). These two reports highlight some of the challenges that are currently faced by young PhD as well as clinician scientists and indicate that changes are needed in training the future biomedical workforce.
As a T32 Principal Investigator/Program Director we would like your input and are asking you for your feedback on some the important questions related to our institutional research training programs as well as the T32 grant mechanism. This survey will allow us to seek your perspectives on key aspects of your research training program that are particularly helpful or challenging.
Your feedback will be very helpful in our review of the overall NIAID T32 portfolio.
Please respond to the survey by xx/xx/2014 and send your response back to me via email.
If you have any questions, please feel free to contact me.
Sincerely and many thanks,
Katrin
Katrin
Eichelberg, MSc, PhD
Office
of Research Training and Special Programs (ORTSP)
DEA/NIAID/NIH/DHHS
5601
Fishers Lane Room #3G51B
Rockville,
MD 20892-9823
Phone:
240-669-2921
Email:
keichelberg@niaid.nih.gov
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
File Title | Expiration Date: 1/31/2016 |
Author | Robbins, Christiane (NIH/NIAID) [E] |
File Modified | 0000-00-00 |
File Created | 2021-01-30 |